The Lab4S Probiotics consortium is the latest addition to our portfolio. It comprises the four probiotic strains from the Lab4 consortia with a strain of Saccharomyces boulardii, specifically developed for use alongside antibiotics.
The Lab4S Probiotics blend was studied in our recent clinical trial, showing its beneficial impact on antibiotic-induced changes in the gut microbiome and antibiotic resistance in the re-growth microbiota.
